LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Thyroid Hormone Levels Linked to Liver Fibrosis in T2D

By LabMedica International staff writers
Posted on 04 Jul 2022
Print article
Image: Abbot Laboratories Free Thyroxine (FT4) Reagent Kit (Photo courtesy of Henry Schlein)
Image: Abbot Laboratories Free Thyroxine (FT4) Reagent Kit (Photo courtesy of Henry Schlein)

Nonalcoholic fatty liver disease (NAFLD) is a clinical pathological syndrome and one of its key characteristics is hepatic steatosis which can be caused by excessive accumulation of fat in the liver.

The liver plays a crucial role in the metabolism of cholesterol and triglycerides (TG). Meanwhile, thyroid hormones interact on hepatic lipid homeostasis through multiple pathways, including stimulation of free fatty acid delivery to the liver for re-esterification to TG, and increasing fatty acid β-oxidation, thereby affecting hepatic fat accumulation.

Endocrinologists at the Anhui Medical University (Anhui, China) carried out a retrospective analysis that included 586 participants, of whom 55.1% were women. They divided participants into groups 346 with and 240 without NAFLD. A NAFLD fibrosis score of > 0.676 served as the definition for progressive liver fibrosis, which the scientists used to categorize participants into two groups: those with (n = 93) and without (n = 493) progressive liver fibrosis.

After separation of serum, fasting blood glucose (FBG), blood fat, liver function, kidney function and albumin (ALB) were measured using an automatic biochemical analyzer (Hitachi, 7600–020, Tokyo, Japan). Fasting C-peptide (FCP) was detected using enzyme-linked immunosorbent assay Autolumo A2000 Plus (Autobio Diagnostics Co., Ltd, Zheng Zhou City, China). High-performance liquid chromatography was performed for the determination of glycosylated hemoglobin (HbA1c) and flow cytometry and the Sysmex XN9000 (Kobe, Japan) and for the determination of platelets (PLT). Chemiluminescence microparticle immunoassay (Abbott ARCHITECT i4000, Abbott Park, IL, USA) was used to measure FT3, FT4, TT3, TT4 and TSH.

The scientists reported that levels of free triiodothyronine, total triiodomethylamine and free T3/free thyroxine ratio were significantly increased whereas the free T4 level was decreased in the group with NAFLD compared with the group without NAFLD. Additionally, compared with participants without progressive liver fibrosis, those with progressive liver fibrosis demonstrated lower levels of free T3, free T4, total T3 and total T4. In logistic regression analysis, a positive relationship between free T3/free T4 ratio and NAFLD was observed, whereas a negative association was reported between free T4 level and NAFLD, and between the risk for progressive hepatic fibrosis and levels of free T4, total T3 and total T4.

The authors concluded that there is a close correlation between the abnormal thyroid hormone levels and liver fibrosis in type 2 diabetes patients. The prevalence of NAFLD increased following the increase of free T3; free T3/free T4 ratio and decrease of free T4. These results suggested that the change of thyroid hormone level in type 2 diabetes patients should be tested routinely for judging the patient’s condition and predicting the prognosis. The study was published on May 31, 2022 in the journal BMC Endocrine Disorders.

Related Links:
Anhui Medical University 
Hitachi 
Autobio Diagnostics Co., Ltd
Sysmex 
Abbott 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more